Detalles de la búsqueda
1.
Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers.
Breast Cancer Res Treat
; 157(1): 157-65, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27113739
2.
High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin & cyclophosphamide in operable breast cancer.
Acta Oncol
; 47(8): 1564-9, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18607846
3.
Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort.
Breast
; 40: 141-146, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29800932
4.
Hormone receptor expression is associated with a unique pattern of metastatic spread and increased survival among HER2-overexpressing breast cancer patients.
Am J Clin Oncol
; 32(5): 504-8, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19564785
Resultados
1 -
4
de 4
1
Próxima >
>>